Pacific Biosciences Of California Net Income 2009-2018 | PACB
Pacific Biosciences Of California net income from 2009 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Pacific Biosciences Of California Annual Net Income (Millions of US $) |
|
|---|---|
| 2018 | $-103 |
| 2017 | $-92 |
| 2016 | $-74 |
| 2015 | $-32 |
| 2014 | $-66 |
| 2013 | $-79 |
| 2012 | $-94 |
| 2011 | $-109 |
| 2010 | $-140 |
| 2009 | $-88 |
| 2008 | $-44 |
| 2007 | $-22 |
| Pacific Biosciences Of California Quarterly Net Income (Millions of US $) |
|
|---|---|
| Q4 2018 | $-31 |
| Q3 2018 | $-25 |
| Q2 2018 | $-23 |
| Q1 2018 | $-24 |
| Q4 2017 | $-21 |
| Q3 2017 | $-22 |
| Q2 2017 | $-26 |
| Q1 2017 | $-24 |
| Q4 2016 | $-19 |
| Q3 2016 | $-17 |
| Q2 2016 | $-18 |
| Q1 2016 | $-19 |
| Q4 2015 | $-1 |
| Q3 2015 | $2 |
| Q2 2015 | $-12 |
| Q1 2015 | $-20 |
| Q4 2014 | $-19 |
| Q3 2014 | $-9 |
| Q2 2014 | $-19 |
| Q1 2014 | $-19 |
| Q4 2013 | $-17 |
| Q3 2013 | $-20 |
| Q2 2013 | $-20 |
| Q1 2013 | $-21 |
| Q4 2012 | $-22 |
| Q3 2012 | $-23 |
| Q2 2012 | $-22 |
| Q1 2012 | $-28 |
| Q4 2011 | $-23 |
| Q3 2011 | $-29 |
| Q2 2011 | $-22 |
| Q1 2011 | $-35 |
| Q4 2010 | $-36 |
| Q3 2010 | $-41 |
| Q2 2010 | $-33 |
| Q1 2010 | $-30 |
| Q4 2009 | $0 |
| Q3 2009 | $-25 |
| Q4 2008 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.102B | $0.079B |
| Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $104.363B | 22.88 |
| Intuitive Surgical (ISRG) | United States | $58.664B | 54.06 |
| Edwards Lifesciences (EW) | United States | $36.977B | 37.03 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $24.585B | 16.83 |
| IDEXX Laboratories (IDXX) | United States | $19.324B | 52.60 |
| Hologic (HOLX) | United States | $13.031B | 19.70 |
| Teleflex (TFX) | United States | $12.848B | 28.14 |
| ABIOMED (ABMD) | United States | $12.211B | 80.60 |
| Varian Medical Systems (VAR) | United States | $12.098B | 30.92 |
| DexCom (DXCM) | United States | $10.817B | 409.72 |
| STERIS (STE) | United Kingdom | $10.794B | 27.74 |
| Masimo (MASI) | United States | $6.762B | 41.98 |
| Penumbra (PEN) | United States | $4.621B | 261.47 |
| Globus Medical (GMED) | United States | $4.518B | 27.42 |
| Integra LifeSciences Holdings (IART) | United States | $4.381B | 20.62 |
| Wright Medical Group (WMGI) | Netherlands | $3.656B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $3.471B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.338B | 20.57 |
| Cantel Medical (CMD) | United States | $2.780B | 27.65 |
| Glaukos (GKOS) | United States | $2.585B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.241B | 18.22 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.994B | 21.66 |
| Nevro (NVRO) | United States | $1.863B | 0.00 |
| Inogen (INGN) | United States | $1.829B | 36.26 |
| OPKO Health (OPK) | United States | $1.436B | 0.00 |
| SILK RD MEDICAL (SILK) | United States | $1.091B | 0.00 |
| CryoLife (CRY) | United States | $1.074B | 115.76 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.046B | 28.42 |
| Accelerate Diagnostics (AXDX) | United States | $1.029B | 0.00 |
| Luminex (LMNX) | United States | $1.000B | 45.37 |
| Veracyte (VCYT) | United States | $0.960B | 0.00 |
| Shockwave Medical (SWAV) | United States | $0.928B | 0.00 |
| Fluidigm (FLDM) | United States | $0.927B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.922B | 175.00 |
| Intersect ENT (XENT) | United States | $0.917B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.903B | 36.95 |
| Natus Medical (BABY) | United States | $0.837B | 17.36 |
| AxoGen (AXGN) | United States | $0.827B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.768B | 26.81 |
| ViewRay (VRAY) | United States | $0.679B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.559B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.514B | 0.00 |
| TransEnterix (TRXC) | United States | $0.436B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.425B | 44.39 |
| Corindus Vascular Robotics (CVRS) | United States | $0.419B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.405B | 0.00 |
| Si-Bone (SIBN) | United States | $0.397B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.375B | 46.36 |
| Accuray (ARAY) | United States | $0.373B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.350B | 0.00 |
| IRadimed (IRMD) | United States | $0.308B | 65.16 |
| Neuronetics (STIM) | United States | $0.288B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.268B | 0.00 |
| Sientra (SIEN) | United States | $0.252B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.208B | 48.17 |
| SOLITON INC (SOLY) | $0.180B | 0.00 | |
| Nuvectra (NVTR) | United States | $0.171B | 0.00 |
| ConforMIS (CFMS) | United States | $0.161B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.152B | 0.00 |
| EDAP TMS (EDAP) | France | $0.142B | 489.00 |
| Alphatec Holdings (ATEC) | United States | $0.137B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.133B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.116B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.110B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.103B | 0.00 |
| Vermillion (VRML) | United States | $0.100B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.076B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.072B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.065B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.060B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.057B | 0.00 |
| Electromed (ELMD) | United States | $0.047B | 24.61 |
| Xtant Medical Holdings (XTNT) | United States | $0.038B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.034B | 0.00 |
| Neovasc (NVCN) | Canada | $0.032B | 0.00 |
| Avinger (AVGR) | United States | $0.032B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.032B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.027B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.026B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.024B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.022B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.020B | 63.67 |
| American Shared Hospital Services (AMS) | United States | $0.016B | 15.11 |
| Dynatronics (DYNT) | United States | $0.016B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.014B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.012B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.010B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.010B | 0.00 |
| Micron Solutions (MICR) | United States | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.006B | 0.00 |
| InspireMD (NSPR) | Israel | $0.006B | 0.00 |
| Presbia (LENS) | Ireland | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.002B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
| ALCON INC (ALC) | $0.000B | 0.00 |
